| __timestamp | Amphastar Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 159205000 | 205018000 |
| Thursday, January 1, 2015 | 174172000 | 392709000 |
| Friday, January 1, 2016 | 150976000 | 299694000 |
| Sunday, January 1, 2017 | 149380000 | 397061000 |
| Monday, January 1, 2018 | 187681000 | 434100000 |
| Tuesday, January 1, 2019 | 190434000 | 782200000 |
| Wednesday, January 1, 2020 | 206506000 | 1119900000 |
| Friday, January 1, 2021 | 238029000 | 2437500000 |
| Saturday, January 1, 2022 | 250127000 | 1560400000 |
| Sunday, January 1, 2023 | 293274000 | 1815800000 |
| Monday, January 1, 2024 | 1970500000 |
Data in motion
In the ever-evolving landscape of pharmaceuticals, understanding cost structures is pivotal. Over the past decade, Regeneron Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc. have showcased distinct trajectories in their cost of revenue. From 2014 to 2023, Regeneron's expenses surged by approximately 785%, peaking in 2021, reflecting its aggressive expansion and innovation strategies. In contrast, Amphastar's costs grew by about 84% during the same period, indicating a more stable growth pattern.
Regeneron's cost of revenue in 2023 was nearly six times that of Amphastar, highlighting its larger scale of operations. This disparity underscores the diverse strategies employed by these companies in navigating the competitive pharmaceutical market. As the industry continues to evolve, these insights provide a window into the financial health and strategic priorities of leading pharmaceutical firms.
Cost Insights: Breaking Down AbbVie Inc. and Amphastar Pharmaceuticals, Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs Intra-Cellular Therapies, Inc.
Cost of Revenue Comparison: Regeneron Pharmaceuticals, Inc. vs Incyte Corporation
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs Lantheus Holdings, Inc.
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Perrigo Company plc's Expenses
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.'s Expenses
Regeneron Pharmaceuticals, Inc. vs Xencor, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Pharming Group N.V. and Amphastar Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: HUTCHMED (China) Limited vs Amphastar Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Amphastar Pharmaceuticals, Inc. vs Xencor, Inc.